REGN-EB3

REGN3470-3471-3479 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN-EB3, covering 2025-11-24 to 2025-11-24. Get the full timeline:

Most recent: Clinical Trial Update: R3470-3471-3479 (REGN-EB3) Expanded Access Protocol (EAP) for Treatment of Ebola Virus Disease